Alpha DNA Investment Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-70	Closed	-$4K	–	382
2021 Q1	$4K	Buy	70 +27	+63%	+$1.54K	﹤0.01%	412
2020 Q4	$3K	Buy	+43	New	+$3K	﹤0.01%	418